A detailed history of Penobscot Wealth Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Penobscot Wealth Management holds 2,761 shares of MRK stock, worth $275,713. This represents 0.17% of its overall portfolio holdings.

Number of Shares
2,761
Previous 2,524 9.39%
Holding current value
$275,713
Previous $319,000 1.57%
% of portfolio
0.17%
Previous 0.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$111.15 - $128.97 $26,342 - $30,565
237 Added 9.39%
2,761 $314,000
Q2 2024

Jul 29, 2024

SELL
$123.8 - $132.96 $2,352 - $2,526
-19 Reduced 0.75%
2,524 $319,000
Q1 2024

May 06, 2024

BUY
$113.24 - $131.95 $8,266 - $9,632
73 Added 2.96%
2,543 $336,000
Q4 2023

Feb 02, 2024

BUY
$100.18 - $109.02 $601 - $654
6 Added 0.24%
2,470 $269,000
Q3 2023

Oct 25, 2023

BUY
$102.95 - $114.33 $253,668 - $281,709
2,464 New
2,464 $254,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Penobscot Wealth Management Portfolio

Follow Penobscot Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penobscot Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Penobscot Wealth Management with notifications on news.